Routine transesophageal echocardiography for cerebral ischemia: Is it really necessary?

Archives of Internal Medicine

Volumn 156, Issue 15, 1996, Pages 1719-1723

  Warner, Mark F ^a   Momah, Kingson I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; BRAIN EMBOLISM; BRAIN ISCHEMIA; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEART ANEURYSM; HEART ATRIUM FIBRILLATION; HEART ATRIUM SEPTUM DEFECT; HEART ATRIUM THROMBOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE;

AGED; ALGORITHMS; BRAIN ISCHEMIA; COST-BENEFIT ANALYSIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0029826056     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.15.1719     Document Type: Article

References (30)

1. Pearson AC, Labovitz AJ, Tatineni S, Gomez CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol. 1991;17:66-72.
2. Pop G, Sutherland GR, Kondstool PJ, Sit TW, de Jong G, Roelandt JR. Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks. Stroke. 1990;21:560-565.
3. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients. Stroke. 1991;22:727-733.
4. Lee RJ, Bartzokis T, Yeoh TK, Grogin HR, Choi D, Schnittger I. Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke. 1991;22:734-739.
5. Aschenberg W, Schluter M, Kremer, P, Schroder E, Siglow V, Bleifeld W. Transesophageal two-dimensional echocardiography for the detection of left atrial appendage thrombus. J Am Coll Cardiol. 1986;7:163-166.
6. Castello R, Pearson AC, Labovitz AJ, Wallace P. Atrial spontaneous contrast in patients undergoing transesophageal echocardiography: prevalence and clinical implications. Am J Cardiol. 1990;65:1149-1153.
7. Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol. 1989;46:727-743.
8. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148-1152.
9. DeRook FA, Comess KA, Albers GW, Popp RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med. 1992;117:922-932.
10. Hofmann T, Kasper W, Meinertz T, Geibel A, Just H. Echocardiographic evaluation of patients with clinically suspected atrial emboli. Lancet. 1990;336:1421-1424.
11. Karolis DG, Chandrasekaran K, Victor MF, Ross JJ, Mintz GS. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol. 1991; 17:73-78.
12. Bougousslavsky J, Hachinski VC, Boughner DR, Fox AJ, Vinuela F, Barnett HJ. Cardiac and arterial lesions in carotid transient ischemic attacks. Arch Neurol. 1986;43:223-228.
13. Harvey JR, Teague SM, Anderson JL, Voyles WF, Thadani U. Clinically silent atrial septal defects with evidence for cerebral embolization. Ann Intern Med. 1986;105:695-697.
14. Belkin RN, Hurwitz BJ, Kisslo J. Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. Stroke. 1987;18:856-862.
15. Barnett HJM, Boughner DR, Taylor DW, Cooper PE, Kostuk WJ, Nichol PM. Further evidence relating mitral valve prolapse to cerebral ischemic events. N Engl J Med. 1980;302:139-144.
16. Tunick PA, Perez JL, Kronzon I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991;115:423-427.
17. Stratton JR, Lighty GW Jr, Pearman AS, Ritchie JL. Detection of left ventricular thrombus by two dimensional echocardiography: sensitivity, specificity, and causes of uncertainty. Circulation. 1982;66:156-166.
18. Daniel WG, Nellessen U, Schroder E, Daniel BN, Bednarski P, Nikutta P. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thrombolic risk. J Am Coll Cardiol. 1988;11:1204-1211.
19. Tsai LM, Chen JH, Fang CJ, Lin LJ, Kwan CM. Clinical implications of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 1992;70:327-331.
20. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: final results. Circulation. 1991;84:527-539.
21. Peterson P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK Study. Lancet. 1989;1:175-179.
22. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cairns JA, Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 1991;18: 349-355.
23. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990;323:1505-1511.
24. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992; 327:1406-1412.
25. Matchar DB, McCrory DC, Barnett HJM, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med. 1994;121:41-53.
26. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk. Ann Intern Med 1992;116:1-5.
27. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation, II: echocardiographic features of patients at risk. Ann Intern Med. 1992;116:6-12.
28. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30-year follow-up in the Framingham Study. JAMA. 1985; 254:3449-3453.
29. Bruns FJ, Segel DP, Adler S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci. 1978;275:105-108.
30. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med. 1987;82:1233-1237.